Edesa Biotech, Inc. SEC filings EDSA

Edesa Biotech, Inc. has 751 filings in SEC EDGAR's recent list, going back to Feb 3, 2012. Its latest annual report, Form ARS, was filed on Apr 3, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (officer or director change). The company's fiscal year ends on September 30.

Edesa Biotech, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 23, 2026 Oct 23, 2026
8-K Current report
Other events
Oct 15, 2026 Oct 15, 2026
8-K Current report
Material agreement, Other events
Aug 20, 2026 Aug 19, 2026
424B5 Prospectus supplement Aug 20, 2026 —
424B5 Prospectus supplement Aug 19, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
EFFECT Filing Jul 13, 2026 —
424B3 Prospectus Jul 13, 2026 —
S-3 Shelf registration Jul 2, 2026 —
D Filing Jun 26, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jun 11, 2026 Jun 10, 2026
8-K Current report
Other events
Jun 5, 2026 Jun 5, 2026
S-8 Employee stock plan registration May 29, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2026 May 27, 2026
8-K Current report
Officer or director change
May 15, 2026 May 13, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
ARS Annual report to shareholders Apr 3, 2026 Sep 30, 2025
DEFA14A Additional proxy material Apr 3, 2026 —
DEF 14A Proxy statement Apr 3, 2026 May 27, 2026
8-K Current report
Other events
Feb 24, 2026 Feb 24, 2026
10-Q Quarterly report Feb 13, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 13, 2026 Feb 13, 2026
8-K Current report
Other events
Dec 12, 2025 Dec 12, 2025
424B5 Prospectus supplement Dec 12, 2025 —
10-K Annual report Dec 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Dec 12, 2025 Dec 12, 2025
8-K Current report
Other events
Oct 28, 2025 Oct 28, 2025
8-K Current report
Material agreement, New debt
Sep 30, 2025 Sep 30, 2025
EFFECT Filing Sep 9, 2025 —
8-K Current report
Other events
Sep 9, 2025 Sep 9, 2025
424B5 Prospectus supplement Sep 9, 2025 —
CORRESP Letter to the SEC Sep 5, 2025 —
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 8, 2025 Aug 8, 2025
UPLOAD Letter from the SEC Jul 30, 2025 —
S-3 Shelf registration Jul 25, 2025 —
S-8 Employee stock plan registration May 28, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
May 28, 2025 May 28, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
ARS Annual report to shareholders Apr 4, 2025 Sep 30, 2024
DEFA14A Additional proxy material Apr 4, 2025 —
DEF 14A Proxy statement Apr 4, 2025 May 28, 2025
8-K Current report
Officer or director change, Other events
Apr 4, 2025 Apr 3, 2025
EFFECT Filing Mar 11, 2025 —
424B3 Prospectus Mar 11, 2025 —
CORRESP Letter to the SEC Mar 7, 2025 —
UPLOAD Letter from the SEC Mar 7, 2025 —
UPLOAD Letter from the SEC Mar 4, 2025 —
S-3 Shelf registration Mar 4, 2025 —
CORRESP Letter to the SEC Feb 26, 2025 —
UPLOAD Letter from the SEC Feb 20, 2025 —
D Filing Feb 14, 2025 —
10-Q Quarterly report Feb 14, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 14, 2025 Feb 14, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
Feb 13, 2025 Feb 12, 2025
10-K/A Amended annual report Dec 20, 2024 Sep 30, 2024
10-K Annual report Dec 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Dec 13, 2024 Dec 13, 2024
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Oct 31, 2024 Oct 30, 2024
424B5 Prospectus supplement Oct 4, 2024 —
8-K Current report
Material agreement, Agreement ended
Oct 4, 2024 Oct 3, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 9, 2024 Aug 9, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 24, 2024 Jun 24, 2024
S-8 Employee stock plan registration May 31, 2024 —
8-K Current report
Officer or director change
May 30, 2024 May 30, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 10, 2024 May 10, 2024
ARS Annual report to shareholders Apr 5, 2024 Sep 30, 2023
DEFA14A Additional proxy material Apr 5, 2024 —
DEF 14A Proxy statement Apr 5, 2024 Apr 3, 2024
10-Q Quarterly report Feb 9, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 9, 2024 Feb 9, 2024
10-K Annual report Dec 15, 2023 Sep 30, 2023
8-K Current report
Results of operations
Dec 15, 2023 Dec 15, 2023
8-K Current report
Other events
Oct 26, 2023 Oct 25, 2023
8-K Current report
Material agreement, New debt
Oct 23, 2023 Oct 20, 2023
8-K Current report
Material agreement, New debt, Regulation FD disclosure, Other events
Oct 12, 2023 Oct 12, 2023
8-K Current report
Change to shareholder rights, Other events
Oct 11, 2023 Oct 10, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Officer or director change
Jun 27, 2023 Jun 26, 2023
8-K Current report
Listing notice
Jun 23, 2023 Jun 22, 2023
S-8 Employee stock plan registration May 24, 2023 —
8-K Current report
Officer or director change, Shareholder vote results
May 24, 2023 May 23, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
ARS Annual report to shareholders Apr 7, 2023 Sep 20, 2022
DEF 14A Proxy statement Mar 28, 2023 Mar 13, 2023
8-K Current report
Material agreement
Mar 27, 2023 Mar 27, 2023
424B5 Prospectus supplement Mar 27, 2023 —
10-K/A Amended annual report Mar 27, 2023 Sep 30, 2022
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 13, 2023
10-Q Quarterly report Feb 10, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 10, 2023 Feb 10, 2023
EFFECT Filing Dec 23, 2022 —
424B3 Prospectus Dec 23, 2022 —
UPLOAD Letter from the SEC Dec 21, 2022 —
CORRESP Letter to the SEC Dec 21, 2022 —
S-3 Shelf registration Dec 16, 2022 —
10-K Annual report Dec 16, 2022 Sep 30, 2022
8-K Current report
Results of operations
Dec 16, 2022 Dec 16, 2022
8-K Current report
Material agreement, Unregistered share sale
Nov 3, 2022 Nov 2, 2022
EFFECT Filing Aug 12, 2022 —
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 12, 2022 Aug 12, 2022
CORRESP Letter to the SEC Aug 10, 2022 —
UPLOAD Letter from the SEC Aug 9, 2022 —
S-3 Shelf registration Aug 5, 2022 —
8-K Current report
Shareholder vote results
May 20, 2022 May 18, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 13, 2022 May 13, 2022
EFFECT Filing Apr 19, 2022 —
424B4 Prospectus Apr 19, 2022 —
UPLOAD Letter from the SEC Apr 15, 2022 —
CORRESP Letter to the SEC Apr 15, 2022 —
S-1 Registration statement Apr 11, 2022 —
D Filing Apr 5, 2022 —
DEF 14A Proxy statement Apr 1, 2022 May 18, 2022
8-K Current report
Officer or director change
Mar 29, 2022 Mar 28, 2022
424B5 Prospectus supplement Mar 23, 2022 —
8-K Current report
Material agreement, Agreement ended, Unregistered share sale
Mar 23, 2022 Mar 21, 2022
424B5 Prospectus supplement Mar 4, 2022 —
8-K Current report
Officer or director change
Mar 4, 2022 Feb 28, 2022
8-K Current report
Material agreement
Mar 4, 2022 Mar 4, 2022
8-K Current report
Officer or director change
Mar 2, 2022 Feb 28, 2022
8-K Current report
Results of operations
Feb 14, 2022 Feb 14, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
424B5 Prospectus supplement Dec 28, 2021 —
10-K Annual report Dec 28, 2021 Sep 30, 2021
8-K Current report
Results of operations
Dec 28, 2021 Dec 28, 2021
8-K Current report
Material agreement
Nov 22, 2021 Nov 22, 2021
424B5 Prospectus supplement Nov 22, 2021 —
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 13, 2021 Aug 13, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 14, 2021 May 14, 2021
S-8 Employee stock plan registration Apr 23, 2021 —
8-K Current report
Officer or director change, Shareholder vote results
Apr 23, 2021 Apr 22, 2021
8-K Current report
Material agreement
Mar 22, 2021 Mar 16, 2021
DEF 14A Proxy statement Mar 3, 2021 Apr 22, 2021
424B5 Prospectus supplement Feb 26, 2021 —
8-K/A Amended current report
Material agreement, Agreement ended
Feb 26, 2021 Feb 25, 2021
8-K Current report
Material agreement, Agreement ended
Feb 26, 2021 Feb 25, 2021
FWP Free writing prospectus Feb 26, 2021 —
424B5 Prospectus supplement Feb 26, 2021 —
FWP Free writing prospectus Feb 25, 2021 —
424B5 Prospectus supplement Feb 25, 2021 —
10-Q Quarterly report Feb 16, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 16, 2021 Feb 16, 2021
8-K Current report
Material agreement, Other events
Feb 3, 2021 Feb 2, 2021
10-K Annual report Dec 7, 2020 Sep 30, 2020
8-K Current report
Results of operations
Dec 7, 2020 Dec 7, 2020
8-K Current report
Material agreement
Sep 28, 2020 Sep 28, 2020
424B5 Prospectus supplement Sep 28, 2020 —
8-K Current report
Other events
Sep 28, 2020 Sep 28, 2020
10-Q Quarterly report Aug 12, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 12, 2020 Aug 12, 2020
10-Q Quarterly report May 15, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 15, 2020 May 15, 2020
8-K Current report
Shareholder vote results
May 14, 2020 May 13, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Apr 23, 2020 Apr 17, 2020
8-K Current report
Other events
Mar 27, 2020 Mar 27, 2020
DEFA14A Additional proxy material Mar 24, 2020 —
DEF 14A Proxy statement Mar 23, 2020 May 13, 2020
EFFECT Filing Mar 6, 2020 —
CORRESP Letter to the SEC Mar 4, 2020 —
UPLOAD Letter from the SEC Feb 27, 2020 —
S-1 Registration statement Feb 25, 2020 —
8-K Current report
Results of operations
Feb 13, 2020 Feb 13, 2020
10-Q Quarterly report Feb 13, 2020 Dec 31, 2019
S-8 Employee stock plan registration Jan 28, 2020 —
8-K Current report
Other events
Jan 9, 2020 Jan 8, 2020
424B5 Prospectus supplement Jan 6, 2020 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 6, 2020 Jan 3, 2020
10-KT Transition report Dec 12, 2019 Sep 30, 2019
8-K Current report
Results of operations
Dec 12, 2019 Dec 12, 2019
DEF 14C Information statement Oct 25, 2019 Oct 22, 2019
8-K Current report
Officer or director change, Shareholder vote results
Oct 25, 2019 Oct 22, 2019
EFFECT Filing Sep 12, 2019 —
UPLOAD Letter from the SEC Sep 10, 2019 —
CORRESP Letter to the SEC Sep 10, 2019 —
S-3 Shelf registration Aug 30, 2019 —
8-K Current report
Other events
Aug 30, 2019 Aug 30, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019
8-K/A Amended current report Aug 14, 2019 Jun 7, 2019
8-K Current report
Results of operations
Aug 14, 2019 Aug 14, 2019
8-K/A Amended current report
Officer or director change
Jun 20, 2019 Jun 7, 2019
8-K Current report
Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
Jun 10, 2019 Jun 7, 2019
8-K Current report
Shareholder vote results
May 30, 2019 May 30, 2019
10-Q Quarterly report May 8, 2019 Mar 31, 2019
DEFA14A Additional proxy material May 8, 2019 —
8-K Current report
Results of operations
May 8, 2019 May 8, 2019
DEFM14A Filing Apr 18, 2019 —
PREM14A Filing Mar 29, 2019 Mar 29, 2019
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change
Mar 8, 2019 Mar 7, 2019
DEFA14A Additional proxy material Mar 8, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EDSA (Nasdaq)
Fiscal year ends
September 30
Incorporated in
British Columbia, Canada
Headquarters
Toronto
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1540159
Former names
Stellar Biotechnologies, Inc. (until May 30, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.